Insights

exclusives

1 min read • April 16, 2024

Boris Jordan Says For Curafleaf Specifically, There Is European Play; Don’t Have To Wait For Catalyst; Major Catalyst Was German News On Taking Cannabis Off Narcotic List; Seen Bullish Sign In First Two Weeks Coming Off Telemedicine Platforms

1 min read • April 16, 2024

From Benzinga’s Cannabis Capital Conference: Curaleaf Chairman Boris Jordan Says In The U.S. Its Ohio And New York Catlayst And Florida Catalyst And What We Think Will Probably Be Pennsylvania Sometime End Of This Year Or Early Next Year We Might See Catalyst There

1 min read • April 16, 2024

From Benzinga’s Capital Cannabis Conference: Gerald Pascarelli SVP, Equity Research At Wedbush Securities On Diversification Says Having A Brand And Portfolio Cohesiveness Is Very Important ,Says Understanding ROI Is Key And You Need To Protect Your Cash

1 min read • April 16, 2024

From Benzinga’s Capital Cannabis Conference: Adam Stettner CEO FundCanna On Diversification Says If You Try To Overdiversify And Do Too Much Diversification, It Will Not Work

1 min read • April 16, 2024

From Benzinga’s Capital Cannabis Conference: Vahan Ajamian Capital Markets Advisor High Tide On Diversification Says We Are Diversifying Products, But Focusing On The Same Consumer

1 min read • April 16, 2024

From Benzinga’s Cannabis Capital Conference: Dustin Milner CEO Talarya Brands On M&A Says We Don’t See ‘First Mover’ Advantages In Newer Markets, Says There Are Lots of Challenges In Newer Markets, Says We Still See Great Opportunities In California

1 min read • April 16, 2024

From Benzinga’s Cannabis Capital Conference: Emily Paxhia Founding Partner & Managing Partner Poseidon Investment Management On M&A Deals Says There Are Lots Of Challanges In California To Do M&A Deals

1 min read • April 16, 2024

From Benzinga’s Cannabis Capital Conference: Emily Paxhia Founding Partner & Managing Partner Poseidon Investment Management On M&A Deal Says We Are Going To See More M&A Activities In Newer Markets That Are Opening Up

1 min read • April 16, 2024

From Benzinga’s Cannabis Capital Conference: Eric Espinoza Vice President Green Life Business Group On M&A Deals Says We Are Seeing Lots Cash And Equity Deals Specifically With Receivership Listings

1 min read • April 16, 2024

From Benzinga’s Cannabis Capital Conference: Dustin Milner CEO Talarya Brands On M&A Says ‘Until There Is A Larger Influx Of Investor Interest Capital Coming In, Any Cash That We Are Utilizing For Acquisition Will Primarily Go For Operations

1 min read • April 16, 2024

From Benzinga’s Cannabis Capital Conference: Emily Paxhia Founding Partner & Managing Partner Poseidon Investment Management On M&A Deals Says We Probably Continue To See Mixed Cash And Stock Deals Because Cost Of Capital Is Expensive Right Now

1 min read • April 16, 2024

From Benzinga’s Cannabis Capital Conference: Former Member Of Congress And Holland & Knight Partner Hon. Ed Perlmutter Said DEA Will Help With 280E And So Forth, And Hopefully We’ll See A Decision This Week, Or Soon

Latest Headlines

View All

5 min read • September 2, 2026

Aurora Urges Shareholders to Reject Curaleaf Offer, Citing Cash, Debt and Voting Rights

10 min read • September 2, 2026

Curaleaf Escalates Aurora Takeover Fight, Attacks Dilution, Cash Burn and Six-Year Turnaround

3 min read • September 2, 2026

Colorado Cannabis Market Nears $19 Billion in Lifetime Revenue, New Report Shows

2 min read • September 2, 2026

UK Medical Cannabis Prescriptions Surge 165% to 1.77 Million; 25%+ High-THC Products Gain Share

7 min read • September 2, 2026

Decibel Cannabis Reduces Share Count to 38.5 Million After 15:1 Consolidation

3 min read • September 1, 2026

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

8 min read • September 1, 2026

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

2 min read • September 1, 2026

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

3 min read • September 1, 2026

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

13 min read • September 1, 2026

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

Browse By Channels

Broad U.S. Equity ETFs

first quarter earnings

illegal cannabis farms

intoxicating hemp-derived products

Macro Economic Events

Market-Moving Exclusives

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

View Insights

Secure Access

exclusives

Boris Jordan Says For Curafleaf Specifically, There Is European Play; Don’t Have To Wait For Catalyst; Major Catalyst Was German News On Taking Cannabis Off Narcotic List; Seen Bullish Sign In First Two Weeks Coming Off Telemedicine Platforms

From Benzinga’s Cannabis Capital Conference: Curaleaf Chairman Boris Jordan Says In The U.S. Its Ohio And New York Catlayst And Florida Catalyst And What We Think Will Probably Be Pennsylvania Sometime End Of This Year Or Early Next Year We Might See Catalyst There

From Benzinga’s Capital Cannabis Conference: Gerald Pascarelli SVP, Equity Research At Wedbush Securities On Diversification Says Having A Brand And Portfolio Cohesiveness Is Very Important ,Says Understanding ROI Is Key And You Need To Protect Your Cash

From Benzinga’s Capital Cannabis Conference: Adam Stettner CEO FundCanna On Diversification Says If You Try To Overdiversify And Do Too Much Diversification, It Will Not Work

From Benzinga’s Capital Cannabis Conference: Vahan Ajamian Capital Markets Advisor High Tide On Diversification Says We Are Diversifying Products, But Focusing On The Same Consumer

From Benzinga’s Cannabis Capital Conference: Dustin Milner CEO Talarya Brands On M&A Says We Don’t See ‘First Mover’ Advantages In Newer Markets, Says There Are Lots of Challenges In Newer Markets, Says We Still See Great Opportunities In California

From Benzinga’s Cannabis Capital Conference: Emily Paxhia Founding Partner & Managing Partner Poseidon Investment Management On M&A Deals Says There Are Lots Of Challanges In California To Do M&A Deals

From Benzinga’s Cannabis Capital Conference: Emily Paxhia Founding Partner & Managing Partner Poseidon Investment Management On M&A Deal Says We Are Going To See More M&A Activities In Newer Markets That Are Opening Up

From Benzinga’s Cannabis Capital Conference: Eric Espinoza Vice President Green Life Business Group On M&A Deals Says We Are Seeing Lots Cash And Equity Deals Specifically With Receivership Listings

From Benzinga’s Cannabis Capital Conference: Dustin Milner CEO Talarya Brands On M&A Says ‘Until There Is A Larger Influx Of Investor Interest Capital Coming In, Any Cash That We Are Utilizing For Acquisition Will Primarily Go For Operations

From Benzinga’s Cannabis Capital Conference: Emily Paxhia Founding Partner & Managing Partner Poseidon Investment Management On M&A Deals Says We Probably Continue To See Mixed Cash And Stock Deals Because Cost Of Capital Is Expensive Right Now

From Benzinga’s Cannabis Capital Conference: Former Member Of Congress And Holland & Knight Partner Hon. Ed Perlmutter Said DEA Will Help With 280E And So Forth, And Hopefully We’ll See A Decision This Week, Or Soon

Aurora Urges Shareholders to Reject Curaleaf Offer, Citing Cash, Debt and Voting Rights

Curaleaf Escalates Aurora Takeover Fight, Attacks Dilution, Cash Burn and Six-Year Turnaround

Colorado Cannabis Market Nears $19 Billion in Lifetime Revenue, New Report Shows

UK Medical Cannabis Prescriptions Surge 165% to 1.77 Million; 25%+ High-THC Products Gain Share

Decibel Cannabis Reduces Share Count to 38.5 Million After 15:1 Consolidation

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

Browse By Channels

Join the Cannabis Revolution

Insights

Insights Tips